HemoGenyx is a biotechnological company that focuses on discovery, development and commercialization of therapies and treatments for blood diseases.
Business Model:
Revenue: $4.9M
Employees: 11-50
Address: 5 Fleet Place
City: London
State: england
Zip: EC4M 7RD
Country: GB
HemoGenyx is a biotechnological company that focuses on discovery, development and commercialization of therapies and treatments for blood diseases.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
10/31/2015
Ticker Symbol:
HEMO
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2020 | Post-IPO Debt | $0 |
Mint Capital Mint Capital |
6/2016 | Post-IPO Equity | $1M | 9/2015 | IPO | $13.2M |
|
10/2014 | Seed Round | 1 | - |
43North 43North |
12/2014 | Seed Round | $250k | 11/2020 | Post-IPO Debt | 1 | $60M |
Mint Capital Mint Capital |
10/2014 | Seed Round | 1 | - |
43North 43North |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|